Ernexa Therapeutics Inc. (ERNA) Other financing activities (2010 - 2026)
Ernexa Therapeutics' (ERNA) quarterly Other financing activities came in at $20000.0 in Q1 2026, up 400.0% YoY from $4000.0 in Q1 2025, and down 23.08% on a QoQ basis from $26000.0 in Q3 2025.
Ernexa Therapeutics Inc. (ERNA) Other financing activities (2010 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 9 years of Other financing activities data on file, last reported at $20000.0 in Q1 2026.
- Quarterly Other financing activities rose 400.0% year-over-year to $20000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46000.0 (up 1050.0% YoY) and the FY2025 annual result came in at $30000.0, changed N/A from the prior year.
- Other financing activities declined to $20000.0 in Q1 2026, from $26000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $26000.0 in Q3 2025 to a low of $4000.0 in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Sep 30, 2021 | 10,202.00 |
| Sep 30, 2021 | 10,202.00 |
| Jun 30, 2021 | 10,202.00 |
| Jun 30, 2021 | 10,202.00 |
| Jun 30, 2020 | -1.17 Mn |
| Jun 30, 2020 | -1.17 Mn |
| Mar 31, 2020 | 1.17 Mn |
| Mar 31, 2020 | 1.17 Mn |
| Jun 30, 2018 | 1.38 Mn |
| Jun 30, 2018 | 1.38 Mn |
| Jun 30, 2015 | 1,000.00 |
| Jun 30, 2015 | 1,000.00 |
| Sep 30, 2014 | 22,000.00 |
| Sep 30, 2014 | 22,000.00 |